CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Casgevy therapy uses technology known as CRISPR/Cas9 to take blood stem cells from a person’s body, edit the harmful DNA, and transplant the genetically modified cells back in. Most people ...

In fact, there are several robot kits that you can purchase that are designed specifically for Raspberry Pi integration. Some of them are easy to assemble and make an excellent option for robo ...

51% of the business is held by the top 14 shareholders Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock Every investor in CRISPR ...

The legacy of our ancient human relatives, "brain-eating-amoeba" infections, emerging viral threats, the promise and peril of genome editing, and much, much more — in 2024, Live Science covered ...

Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University, Chongqing 400044, PR China ...